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Abstract
Ketamine hydrochloride is a well known general anesthetic and short acting analgesic in use for almost 3 decades. The role of the NMDA
receptor in the processing of nociceptive input has led naturally to renewed clinical interest in N-methyl-o-aspartate (NMDA) receptor
antagonists such as ketamine. This paper reviews the use and efficacy of low-dose ketamine in the management of acute postoperative pain.
The literature was obtained from a computer search of the MEDLINE@ database from 1966 through December 1998. Studies were included
for review if they were randomized, prospective, controlled, double-blind and reported pain scores. We evaluate the clinical literature and
discuss the efficacy of low-dose ketamine in the management of acute postoperative pain when administered alone or in conjunction with
other agents via the oral, intramuscular, subcutaneous, intravenous and intraspinal routes. Low-dose ketamine is defined as a bolus dose of
less than 2 mg/g when given intramuscularly or less than 1 mg/kg when administered via the intravenous or epidural route. For continuous i.v.
administration low-dose ketamine is defined as aftte of 
=20 pglkg per min. We conclude that ketamine may provide clinicians with a tool to
improve postoperative pain management and to reduce opioid related adverse effects. The evidence suggests that low-dose ketamine may
play an important role in postoperative pain management when used as an adjunct to local anesthetics, opioids, or other analgesic agents.
Further research is required in the following areas: (a) dose-finding studies for ketamine as an adjunct to opioids and local anesthetics (b)
efficacy and optimal route of administration (c) the role of S(+)-ketamine; (d) the influence of ketamine on long-term outcome such as
chronic pain (e) long-term physical and chemical stability of mixtures containing ketamine (0 spinal toxicity of ketamine and (g) effects of
low-dose ketamine on cognitive and memory functioning after surgery. @ 1999 International Association for the Study of Pain. Published by
Elsevier Science B.V.
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1. Introduction
A variety of substances and modalities are cunently in
use for the management of postoperative pain. To optimize
pain management and outcome there is a continuous search
for new analgesics and alternative routes of delivery. Keta-
mine is a well known general anesthetic and short acting
analgesic in use for almost 3 decades. The recent discovery
of the N-methyl-n-aspartate (NMDA) receptor (Foster and
Fagg, 1987) and its links to pain processing and spinal
neural plasticity triggered renewed interest in ketamine as
x Corresponding author. Department of Psychology, Toronto General
Hospital, 200 Elizabeth Street, CW 2-318, Toronto, ON M5G 2C4,Camda.
Tel.t l-416-340-3777; fax: * l-416-340-4739.
E-mail address: j.katz@utoronto.ca (J. Katz)
rPresent 
address: An der Vogelweide 5I,D-53229 Bonn, Germany.
a potential anti-hyperalgesic agent (Wilcox, l99l) given its
actions as a non-competitive NMDA-receptor antagonist.
Ketamine has found a niche as a general anesthetic agent
for various procedures in anesthesia and emergency medi-
cine. Its usefulness, however, has been limited by its unde-
sirable psychic emergence effects and cardiovascular
stimulating properties. It therefore, remains a controversial
drug to many anesthetists who remain wary of its adverse
effects. However, it is becoming increasingly clear that a
distinction must be made between the use of high-dose
ketamine as an anesthetic agent and the use of low-dose
ketamine for analgesic or anti-hyperalgesic effects. There
may even be a third dose range in which ketamine has no
analgesic potency on its own but when used in combination
with an opioid, yields an opioid sparing effect and superior
pain relief than either drug alone (Chapman and Dickenson,
1992: Dickenson, 1993).
In this review we briefly summarize the pharmacology of
ketamine. We then evaluate and discuss the effectiveness
and usefulness of low-dose ketamine in its different modes
of application in the management of postoperative pain.
Finally, we offer clinical recommendations and suggestions
for future research.
For the purpose of the present review, low-dose ketamine
is defined as a bolus dose of less than 2 mglkg when given
intramuscularly or less than I mg/kg when administered via
the intravenous or epidural route. For continuous i.v. admin-
istration low-dose ketamine is defined as a rate of <20 p"gl
kg per min.
2. Pharmacology
Ketamine (CI-581, Ketalar@) was developed in a search
for an 'ideal' anesthetic. Ketamine was first synthesized by
Stevens (1963) as a further development of phencyclidine
and its congener cyclohexamine and was approved for clin-
ical use in 1970. The ketamine molecule 2-(o-chlorophe-
nyl)-2-(methylamino) cyclohexanone has a molecular
weight of 238 (Silvay, 1983), is soluble in water to 207o
(Corssen and Domino, 1966), and has a pK" of 7.5 (Cohen
and Trevor, 1974). The aqueous solutions of ketamine
hydrochloride in clinical use have a pH range from 3.5 to
5.5. Under physiologic conditions the uncharged form of
ketamine is highly lipid soluble (10 times that of thiopen-
tone (Reich and Silvay, 1989)). It is available as a racemic
mixture that contains equal amounts of the two isomers
S(*)-ketamine and R(-)-ketamine. In both animals and
humans S(*)-ketamine is 3-4 times more potent than
R(-)-ketamine for pain relief (Marietta et al., 1977;
Ryder et al., 1978; White et al., 1985; Oye et al., 1992;
Mathisen et al., 1995;) and in equianalgesic doses, produces
fewer psychic disturbances and less agitation than R(-)-
ketamine or the racemate (Marietta et aL., 1977; Ryder et
al.,1978; White et al., 1980; Calvey, 1995) but see (Schut-
tler,1992; Mathisen et al., 1995).
2.1. Pharmacodynamics
Ketamine acts on a variety of receptors, including nico-
tinic (Scheller et al., 1996) and muscarinic (Hustveit et al.,
1995) receptors. Ketamine blocks peripheral and human
central nervous system sodium channels (Scheller et a1.,
1996), it interacts with mu (p), delta (6), and kappa (rc)
opioid receptors (Smith et al., 1980; Finck and Ngai,
1982; Hustveit et al., 1995) and interacts with monoaminer-
gic and voltage sensitive Ca-- channels (Hirota and
Lambert, 1996). Ketamine also acts as a non-competitive
antagonist (see below) at the phencyclidine receptor site in
the NMDA receptor complex channel (Willetts et al., 1990;
Yamamura et al., 1990).
The role of the NMDA receptor in the processing of
nociceptive input led naturally to renewed clinical interest
in NMDA receptor antagonists such as ketamine (Ilkjaer et
aI., 1996). Low-dose ketamine induces a use-dependent,
non-competitive blockade (Dickenson, 1995), also referred
to as an 'uncompetitive blockade' (Rogawski, 1993; Orser
et aL, 1997), meaning that the rate of onset and recovery of
the block depends on agonist binding at a different receptor
site. This implies that the receptor channel has to be in the
open state before ketamine can bind to or dissociate from
the blocking site presumed to be situated within the channel
pore (Orser et al., 1997). This raises the possibility that
ketamine can become 'trapped' in the receptor channel
until the channel reopens after agonist activation (Foster
and Fagg, 1987). A second NMDA receptor binding site
for ketamine has been reported that is associated with the
hydrophobic domain of the protein (Orser et aI., 1997).
Binding at the former receptor site (in the channel)
decreases channel open time, whereas binding at the latter
site decreases the frequency of channel opening.
3. Use of ketamine for postoperative pain management
3. l. Data identification
The literature referenced in this review was obtained from
a computer search of the MEDLINET database from 1966
through December 1998.
Of the 50 studies identified, those publications which
fulfilled the following criteria were chosen for in depth
analysis and discussion: randomized, prospective,
controlled, double-blind and reporting pain scores. A total
of 28 publications (567o) met the above criteria. The 22
(MVo) remaining studies which did not fulfill these criteria
are identified in Table I without additional comment. Due to
the different study objectives and study designs, a meta-
analysis of the published data was not deemed appropriate.
4. Routes of administration
In this section, we describe the different routes of keta-
mine administration in the treatment of postoperative pain.
This is followed by a brief summary of outcomes based on
the studies that fulfill the above stated criteria.
4.1. Oral, rectal and intranasal ketamine
The oral, rectal, and intranasal routes of administration of
ketamine have been evaluated extensively to provide
premedication for general anesthesia (Weksler et al.,
1993; Alderson and Lerman, 1994; Warner et al., 1995;
Cioaca and Canavea, 1996) or sedation for a variety of
surgical procedures (Abrams et al., 1993; Alfonzo-Eche-
verri et a1.,1993; Louon and Reddy, 1994). The analgesic
efficacy of oral ketamine has only been examined in chil-
dren requiring laceration repair (Hollman and Perloff,
1995). The analgesic effects of oral, rectal and intranasal
ketamine in the postoperative setting either as an adjunct
Table I
Studies not fulfilling inclusion criteria"
l.m.
s.c.
i.v.
i.v.
i.v.
i.v.
i.v.
i.v.
Epidural
Epidural
Epidural
Epidural
Epidural
Epidural
Epidural
Epidural
Epidural
Epidural
Epidural
Epidural
Epidural
u R, randomized; C, controlled; DB, double-blind; P, patient-rated pain.
to opioid analgesia or as the sole agent have not been deter-
mined.
4.2. Intramuscular ketemine
Ketamine is rapidly absorbed after intramuscular injec-
tion with an absorption half life of 2-ll min. After injection
it appears in the plasma in less than 4 min ( : lag time) and
has a bioavailability of 937o. The mean -t- SE terminal
plasma half life is 155 -r 12 min (Clements and Nimmo,
1981).
A variety of doses have been administered ranging from
0.44 mgkg (Sadove et al., l97l; Parkhouse and Marriott,
191'7) to 1.0 mg/kg (Dich-Nielsen et a1., 1992) (Table 2).
Ketamine has been given as a single bolus injection (Sadove
et aI., l9ll; Parkhouse and Marriott, 1977; Hagelin and
Lundberg, 1981; Mathisen et al., 1995) or on demand
(Dich-Nielsen et al., 7992) to patients undergoing a variety
of surgical procedures (e.g. abdominal surgery, orthopedic
surgery, thoracic surgery and orofacial surgery). Intramus-
cular ketamine has been administered as a sole analgesic
agent (Sadove et al., 1971; Mathisen et al., 1995) or in
combination with meperidine (Parkhouse and Marriott,
1977; Hagelin and Lundberg, 1981; Dich-Nielsen et al.,
1992\.
The results of these studies indicate that an intramuscular
bolus of ketamine alone (0.5-1.0 mg/kg) is effective with a
12 fold analgesic potency (mg/mg) of that of i.m. pethi-
dine. Most studies involved only single injections. Pain
relief was rapid in onset (within 5 min) and lasted from
0.5 h (Sadove et al., l97l) to 2 h (Hagelin and Lundberg,
l98l). Combining ketamine with an opioid may prolong
analgesia compared with opioids or ketamine alone (Park-
house and Maniott, 1977). Low-dose intramuscular keta-
mine (0.5-l mg/kg) does not appear to have hemo-
dynamic or respiratory depressant effects (Hagelin and
Lundberg, l98l; Dich-Nielsen et aI., 1992). Sedation,
psychotomimetic effects and other adverse reactions asso-
ciated with low-dose i.m. ketamine are infrequent and dose-
related (see Table 2).
4.3. Subcutaneous ketamine
Subcutaneous (s.c.) administration of drugs has the poten-
tial advantage of relatively even and slow absorption into
the bloodstream (Schwinn et al., 1994). This prevents high
peak blood levels that occur after intravenous bolus admin-
istration. Low-dose (1.7 p,glkg per min) s.c. ketamine admi-
nistered after major abdominal surgery did not produce
adverse effects and provided postoperative analgesia
equivalent to a s.c. morphine infusion of 2 mglh (Bhatta-
charya et aI., 1994).
4.4. Intravenous ketamine
Ketamine is distributed rapidly after intravenous admin-
istration with a bioavailability of 93Vo (Grant et al., 1981).
Thereafter, plasma levels fall rapidly; however, the mean
terminal half life is 186 + l0 min fitting a two compartment
open model (Clements and Nimmo, 1981). The studies
using i.v. ketamine have heterogeneous designs (Table 3).
Ketamine has been administered as either a single bolus
injection (Maurset et al., 1989; Ngan Kee et al., 1997),
bolus injection followed by a continuous infusion
(Joachimsson et al., 1986; Owen et al., 1987; Jahangir et
al., 1993), continuous infusion (Clausen et al., 1975),
continuous infusion combined with either an opioid or a
benzodiazepine (Edwards et al., 1993; Jahangir et a1.,
1993; Stubhaug et a1., 1997; Wilder-Smith et al., 1998), or
via a patient-controlled device (PCA) (Javery et al., 1996).
In some studies opioid rescue medication was made avail-
able to patients. Studies in Table 3 can be categorized as
follows: bolus injection, bolus injection plus continuous
infusion, continuous infusion, or patient-controlled.
Taken together these studies suggest that analgesic effi-
cacy of i.v. ketamine depends on infusion rate, initial load-
ing dose and whether concomitant opioids are administered
(Table 4). Ketamine produces effective but short acting pain
relief when administered as a single bolus of > 300 pg/kg
(Maurset et al., 1989). Ketamine does not have any effect on
postoperative pain or morphine consumption when adminis-
tered (without a loading dose) as a continuous infusion of
less than 4 p,gkg per min (Edwards et aI.,1993).In combi-
nation with a loading dose however, ketamine infusion rates
of 1-6 pg/kg per min provide evidence ofanti-hyperalgesic,
analgesic and opioid sparing effects (Owen et al., 1987;
Jahangir et al., 1993; Stubhaug et al., 1997). At higher
doses, ketamine appears to provide an equivalent degree
of postoperative pain relief as do opioids, but onset can be
Author and year Criteria not fulfilled
Mathisen et al., (1995)
Bristow and Orlikowski (1989)
Ito and Ichiyanagi (1974)
Austin (1981)
Dick et al., (1983)
Knoche et al. (1983)
Forestner (1988)
Hartvig et al. (1993)
Islas et al. (1985)
Chung et al. (1986)
Naguib et al. (1986)
Ravat et al. (1987)
Kawana et al. (1987)
Jiang et al. (1988)
Naguib et al. (1991)
Cook et al. (1995)
Semple et al. (1996)
Yanli and Eren (1996)
Kucuk et al. (1998)
Weir and Fee (1998)
Findlow et al. (7997)
R, C, DB
DB, P
R, C, DB,P
R, C, DB
C, DB
C, DB
R, C, DB, P
R, C, DB, P
R, C, DB
R, C, DB
C, DB
C, DB
P
DB
C, DB
DB, P
DB, P
P
DB
P
C, DB, P
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Table 4
Analgesic efficacy of intravenous ketamine with or without bolus administration or concomitant opioids
Reference Ketamine regime Outcome
Infusion (pg/kg per min) Bolus (pg/kg) Concomitant opioid Analgesic effect Opioid sparing effect
Maurset et al. (1989)
Javery et al. (1996)
Wilder-Smith et al. (1998)
Edwards et al. (1993)
Stubhaug et al. (1997)
Owen et al. (1987)
Jahangir et al. (1993)
Clausen et al. (1975)
Joachimsson et al. (1986)
Yes
No
No
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
No
No
Yes
No
No
No
It
4
o
t4
t4
300
t4
500/250
No
500
1000
500
No
500
Yes
2
Yesu
No
Yesb
Yes
Yes
Yes
Yes Yes
" Anti-hyperalgesic.
b Anti-hyperalgesic and analgesic (6 h).
delayed by several hours if a loading dose is not also admi-
nistered. A value for the analgesic potency of ketamine
alone cannot be calculated from the available studies.
Low-dose i.v. ketamine is a potent and safe adjunct to
systemic opioid analgesia. When ketamine (1.0-14.0 pglkg
per.min following a loading dose) is combined with opioid
administration, the combination is associated with better
pain relief and an opioid-sparing effect as large as 507o.
When compared with opioids alone, the PCA opioid-sparing
effect of ketamine is evident even at minimal bolus doses
(e.g. 14.0 pg/kg i.v. ketamine) (Javery et al., 1996). At the
doses reported above, ketamine has not been found to cause
any significant cardiovascular or respiratory effects. Seda-
tion, dreams, hallucinations and other psychotomimetic
adverse reactions are infrequent and the incidence increases
with dose.
4.5. Intraspinal ketamine
Intraspinal techniques include caudal ketamine or caudal
ketamine with local anesthetics, lumbar epidural ketamine,
lumbar epidural ketamine with local anesthetics and/or
opioids and thoracic epidural ketamine with opioids. Keta-
mine is rapidly absorbed from the epidural space into the
systemic circulation with a mean bioavailability ( + SD) of
l7 + 22Vo. However. slow release from the CSF results in
decreased levels of metabolites (Pedraz et al., 1987).
Animal studies have demonstrated the safety of intrathe-
cal l%o ketamine with preservative after a single dose
(Brock-Utne et al., 1982) and for ketamine without preser-
vative after multiple doses (Borgbjerg et al., 1994).
However, both the preservative itself (Malinovsky et al.,
1993) and preservative-free (Yaksh, 1996) ketamine may
induce spinal toxicity and therefore, should not be injected
intraspinally in humans. It should be noted that ketamine has
not been licensed for epidural administration anywhere in
the world.
Case reports, comments and studies of epidural ketamine
are numerous (Mankowitz et aI., 1982; Amiot et al., 1985;
Islas et al., 1985; Ivankovich and McCarthy, 1986; Naguib
et al., 1986; Kawana et al., 1987; Ravat et al., 1987 ; Van der
Auwera et al, 1987; Naguib and Adu-Gyamfi, 1988).
However, excluding studies in which ketamine is adminis-
tered pre-emptively (described below), there are only three
controlled clinical studies (Table 5) in which the efficacy of
epidural ketamine has been assessed. These studies indicate
that epidural ketamine as the sole agent does not provide
effective postoperative analgesia (Peat et al., 1989; Wong et
aI., 1997 ). In combination with epidural morphine, low-dose
ketamine exerts an opioid-sparing effect and provides
improved pain relief compared with epidural morphine
alone (Wong et al., 1997; Chia et al., 1998).
5. Preemptive ketamine
The rationale for preemptive analgesia in the manage-
ment of postoperative pain has been reviewed in detail
(Katz et al., 1992; Coderre et al., 1993; Dahl and Kehlet,
1993; Woolf and Chong, 7993;Katz,1995). Since ketamine
is an NMDA-receptor antagonist, it is hypothesized to
prevent or reverse (already established) central sensitization
and thus to reduce postoperative pain. Initial results using
ketamine preemptively are encouraging. Studies investigat-
ing preemptive analgesic effects of ketamine fall into two
groups depending on the route of administration; either i.v.
or epidural (Table 6).
Low-dose ketamine administered i.v. (Murray et al.,
1987; Roytblat et al., 1993; Tverskoy et al., 1994; Fu et
aI., 1997) or via the epidural route (Choe et al., l99l;
Wong et aI.,1997: Abdel-Ghaffar et al., 1998) resulted in
reduced postoperative pain intensity and/or analgesic
consumption. This appears to be the case whether ketamine
is given in conjunction with an opioid or a local anesthetic
or as the sole asent.
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6. Miscellaneous
In this section we summarize the studies that could not be
categorized under one of the above headings.
The postoperative analgesic effects of preoperatively
administered i.v. ketamine (0.2 mglkg) or i.v. fentanyl (1
pg/kg) were evaluated followed by administration of bupi-
vacaine or i.t. neostigmine and bupivacaine (Lauretti and
Azevedo, 1996) (Table 7). Co-administration of ketamine
with intrathecal neostigmine showed a clear and prolonged
postoperative analgesic effect.
Tverskoy etal. (1996) compared the analgesic effects of
wound infiltration after herniorrhaphy using a mixture of
bupivacaine (0.5Vo) and ketamine (0.357o) or bupivacaine
alone (O.5Vo). Addition of ketamine enhanced both the local
anesthetic and analgesic effects of bupivacaine wound infil-
tration. Similar findings were also reported in which keta-
mine and bupivacaine or bupivacaine alone was infiltrated
into the wound at the end of surgery. A peripheral mechan-
ism of action of ketamine is suggested by these investiga-
tors.
7. Pharmacologic effects
Postoperative pain management is usually limited by
adverse effects. In this section, we briefly summarize the
pharmacological effects of low-dose ketamine on respira-
tion, cardiovascular function. sedation. nausea and vomit-
ing, urinary retention, constipation/prolonged adynamic
postoperative ileus and psychological function. There is
no evidence to indicate that low-dose ketamine (up to I
mg/kg) causes or contributes to respiratory depression
(Maduska and Hajghassemali, 1978; White et al., 1982;
Bourke et aL, 1987; Owen et al., 1981; Peat et al., 1989;
Edwards et aI., 1993; Jahangir et al., 1993; Bhattacharya et
a1.,1994).
Studies examining cardiovascular response to low-dose
ketamine report minimal changes in heart rate and blood
pressure (Sadove et al., l97l; Hagelin and Lundberg,
l98l; Owen et al., 1987; Dich-Nielsen etal.,1992: Edwards
et al., I99 3 ; Jahangir et al., 1993 ; Bhattacharya et al., 199 4).
Two studies (Joachimsson et al., 1986; Roytblat et a1.,1993)
found a decrease in heart rate and blood pressure which was
attributed to a decrease in pain.
Low-dose ketamine may cause mild sedation (Sadove et
aI., l91l) that is less than the sedation seen with opioids
(Bristow and Orlikowski, 1989; Bhattacharya et al.,1994).
In combination with opioids, low-dose ketamine does not
appear to aggravate or contribute to opioid-induced sedation
(Javery et al., 1996; Stubhaug et al.,1997).
Clinical studies have not investigated the emetic or antie-
metic effects of low-dose ketamine. However. when low-
dose ketamine was used alone or in conjunction with an
opioid in the treatment of postoperative pain, the incidence
of postoperative nausea and vomiting was significantly
reduced compared with morphine alone (Bhattacharya et
al., 199 4; Gurnani et al., 199 6; Javery et al., 199 6; Stubhaug
et aI.,1997). This may be due to the opioid-sparing effect of
ketamine. However, when low-dose ketamine is adminis-
tered to healthy volunteers, incidence of nausea and vomit-
ing appears to be greater than that reported in the clinical
setting (Krystal et al., 1998; Sethna et al., 1998).
Urinary retention was found to be less common in
patients using a PCA device administering a mixture of
morphine and ketamine compared with PCA-morphine
alone (Javery et al., 1996). Similar results were obtained
when a continuous subcutaneous ketamine infusion was
compared with a continuous subcutaneous morphine infu-
sion (Bhattacharya et al., 1994).
There is no evidence that ketamine delays gastric empty-
ing or gastro-coecal transit time (Grant et al., 1981; Freye
and Knufermann. 1994).
8. Psychotomimetic effects and impairment in cognitive
functioning
Disturbing emergence reactions (e.g. hallucinations, bad
dreams) have limited the clinical usefulness of ketamine.
The incidence varies from 5Vo to greater than 30Vo (White
et al.,1982) after high dose ketamine anesthesia. Several
factors associated with psychotomimetic effects include
age, sex, subjects who normally dream or have a history
of psychopathology, high doses of ketamine ( > 2 mgkg,
i.v.) and rapid intravenous administration ( > 40 mg/min)
(white er al., 1982).
Six studies have examined the effects of low-dose keta-
mine administered to healthy volunteers (Table 8). Only one
study was specifically designed to assess the effects of low
dose ketamine on cognitive functioning and experimentally
induced pain (Sethna et al., 1998). In the remaining five
studies ketamine was administered to evaluate the psychia-
tric effects of NMDA receptor antagonism. Taken together,
the results of these studies suggest that i.v. low-dose keta-
mine given at an infusion rate < 2.5 p"gkg per min (esti-
mated plasma levels: < 50 ng/ml) does not cause
hallucinations (Krystal et al., 19941, 1998) or impairment
of cognitive functioning (Krystal et al., 1994; Sethna et
al., 1998). Other adverse effects such as a sense ofintoxica-
tion, dizziness, blurred vision, itching or nausea and vomit-
ing occur more commonly but the incidence of these
adverse effects does not appear to differ from that of opioids
(Sethna et al., 1998). At higher doses and plasma levels (200
ng/ml), incidence of cognitive and memory impairments,
psychiatric symptoms, illusory experiences and other
adverse effects increases (Krystal et al., 1994', 1998; Adler
et al., 1998; Bowdle et al., 1998; Sethna et a1., 1998).
In contrast to the research on healthy volunteers, studies
of the effects of low-dose ketamine on perception, cognition
and memory functioning in the acute postoperative setting
have not been conducted. However, most trials do report the
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presence or absence of adverse effects including alterations
in perception. These are described as 'floating in space'
(Joachimsson et al., 1986; Maurset et al., 1989) or as a
'feeling of unreality' (Ito and Ichiyanagi, 1974), are
reported infrequently, and occur in the high end of the
low-dose range. The incidence of bad dreams or hallucina-
tions is low or equals that of opioids (Dich-Nielsen et al.,
1992). However, in two studies by the same research group,
a total of 5 of 85 patients had severe enough psychotomi-
metic effects to require benzodiazepines or to be withdrawn
from the study (Wong et a1.,1996; Wong et al., 1997).
Taken together, in the clinical postoperative setting, the
pharmacologic profile of adverse effects of low-dose keta-
mine appears to be less worrisome than that of opioids or
NSAIDs. The incidence of psychotomimetic effects and
cognitive impairment is negligible at doses less than 2.5
p,g/kg per.min i.v. and increases with higher doses. Within
limits, and under appropriate monitoring, low-dose keta-
mine can be used safely either by itself or as an adjunct to
traditional opioid analgesic therapy in the management of
postoperative pain.
9. Conclusions and recommendations
Despite the many studies examining the use of ketamine
in the treatment of acute postoperative pain, most are diffi-
cult to interpret due to fundamental problems with design,
methods or statistical treatment of data. The following
conclusions and recommendations are based only on studies
that are randomized, prospective, double-blind, controlled
and employ pain rating measures.
Low-dose ketamine as the sole analgesic agent reduces
pain significantly using the following routes: i.m., s.c. and
i.v. However a number of qualifications apply: i.m. keta-
mine may be suitable for short-term use only, and i.v. keta-
mine appears to provide satisfactory pain relief only at the
upper end of the low-dose range (1 mg/kg) with an increased
risk of psychotomimetic adverse effects. For certain clinical
conditions (e.g. asthma, allergies) taking the risk-benefit
relationship into consideration, ketamine (i.m., s.c., i.v.)
might provide an alternative to conventional opioid analge-
sia (Jahangir et al., 1993).
There is little evidence that epidurally administered low-
dose ketamine by itself provides effective postoperative
analgesia, which is in line with recent findings in a rat
model for postoperative pain (Zahn and Brennan, 1998).
However, since both the preservative itself (Malinovsky et
al., 1993) and preservative-free (Yaksh, 1996) ketamine
may be associated with spinal toxicity it is recommended
that ketamine not be injected intraspinally in humans.
There is a growing body of evidence that low-dose keta-
mine may play an important role in postoperative pain
management when used as an adjunct to local anesthetics,
opioids, or other analgesic agents. Duration of analgesia is
increased when ketamine is added to a local anesthetic solu-
tion for wound infiltration (Tverskoy et al., 1996). Ketamine
in combination with opioids, either i.v. (continuous infu-
sion, PCA) or epidurally, not only reduces opioid consump-
tion but also prolongs and improves analgesia (Joachimsson
et al., 1986; Javery etal.,1996; Wong et al.,1996; Stubhaug
et al., 1997). This has also been observed after addition of
low-dose i.v. ketamine to i.t. bupivacaine and neostigmine
(Joachimsson et al., 1986; Javery et a1.,1996; Wong et al.,
1996; Stubhaug et al., 1997). The concept of 'balanced
analgesia' (Dahl et al., 1990) merits attention (Dickenson,
1993), given the limits of opioid analgesia (Kehlet et al.,
1996).
Pharmacological studies suggest that synergistic analge-
sic effects can be achieved by adding low-dose ketamine to
opioids with the consequence of low-adverse effect liability
(Hance et al., 1 989; Chapman and Dickenson, 1992; Honore
et al., 1996). However, a recent study of healthy volunteers
found an additive, but not a synergistic, effect of ketamine
and alfentanil. (Sethna et al., 1998). An additive effect is
most likely a result of the combination of presynaptic opioid
inhibition reducing afferent transmission by diminished
transmitter release, and postsynaptic NMDA blockade
which reduces wind up and central sensitization (Dicken-
son, 1994). A second mechanism underlying reduced opioid
consumption might be the role of the NMDA receptor in the
development of morphine tolerance. Recent observations
suggest that the development of hyperalgesia and morphine
tolerance are closely related and based on common neural
substrates and intracellular events (Trujillo and Akil, 1994;
Mao et al., 1995). Thus, the effects of low-dose ketamine at
the NMDA receptor should not be considered 'analgesic' in
the traditional sense of the term, but rather 'anti-hyperalge-
sic','anti-allodynic' and possibly'tolerance-protective'.
The potential of low-dose ketamine may lie in its comple-
mentary and synergistic effects when combined with other
analgesic agents (Dickenson, 1993; Yaksh, 1996). In this
context, the concerns about the use of ketamine in post-
operative pain management (Hirota and Lambert, 1996)
need reconsideration. As one of the two clinically available
NMDA receptor antagonists, ketamine may provide clini-
cians with a tool to improve postoperative pain management
and to reduce opioid related adverse effects.
Results of studies evaluating efficacy of preemptive keta-
mine are promising and consistent with the pharmacology
and the physiological importance of NMDA receptors
outlined earlier. However, further well designed studies
are required before any final conclusion can be drawn.
Taken together, the role of ketamine in the treatment of
postoperative pain remains controversial. On its own, keta-
mine remains a rescue drug for situations in which other
analgesics are contraindicated. However, as an adjunct in
combination with opioids or local anesthetics, low-dose
ketamine, especially in the 'sub-psychotomimetic' range
(blood concentration < 50 ng/ml), may have an important
role to play in the management of postoperative pain.
Further research is required in the following areas: (a)
dose-finding studies for ketamine as an adjunct to opioids
and local anesthetics (b) efficacy and optimal route of
administration (intravenous vs. epidural vs. spinal) (c) the
role of S(+)-ketamine (d) the influence of ketamine on
long-term outcome such as chronic pain (e) long-term
physical and chemical stability of mixtures containing keta-
mine (f) spinal toxicity of ketamine and (g) effects of low-
dose ketamine on cognitive and memory functioning after
surgery.
Future studies should be carefully designed and whenever
possible, conducted in a randomized, double-blind,
controlled fashion. Pain should be rated by the patient
using a reliable and valid pain scale (e.g. VAS). Rescue
medication should be preferably administered using PCA.
Outcomes other than pain and analgesic use (e.g., adverse
effects, duration of hospital stay and cost -benefit analysis)
should be included whenever possible.
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